PI-3 kinase inhibitor prodrugs

Details for Australian Patent Application No. 2004228668 (hide)

International Classifications

Event Publications

6 October 2005 PCT application entered the National Phase

PCT publication WO2004/089925 Priority application(s): WO2004/089925

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

19 November 2009 Section 223 Application Received

Semafore Pharmaceuticals, Inc. An application to extend the time from 03 Apr 2009 to 03 Nov 2009 in which to pay a continuation fee has been filed . Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

21 January 2010 Section 223 Application Allowed

Semafore Pharmaceuticals, Inc. The time in which to pay a continuation fee has been extended to 03 Nov 2009. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000 Extensions of Time, Section 223

20 October 2011 Assignment before Grant

Semafore Pharmaceuticals, Inc. The application has been assigned to Park Funding, LLC 2005

27 October 2011 Application Accepted

Published as AU-B-2004228668

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.